Indian pharma stocks head for worst day in 3-1/2 years on Trump's tariff threat

Indian pharma stocks slide 4.2% after U.S. President Donald Trump threatened the sector with tariffs

Nifty Pharma .NIPHARM index set for its worst day since July 2021, if losses hold

Pharma stocks rose on Thursday after being exempted from the U.S. reciprocal tariffs, despite Washington imposing a 26% tariff on India

"Pharma (tariffs) is going to be starting to come in, I think, at a level that you haven't really seen before," Trump told reporters aboard Air Force One

All 20 stocks on the pharma index in the red on Friday, with heavyweights Cipla CIPL.NS, Sun Pharma SUN.NS and Dr. Reddy's REDY.NS down 6%, 3.6%, 4.3%, respectively

Pharma index extends YTD losses to 12.3% vs a 2.7% fall in blue-chip Nifty 50 .NSEI index